Treatment of Malignant Neoplasm of Commissure of Lip in Advanced-Stage Inoperable Lip Cancer Fit for Chemotherapy

This protocol addresses patients with malignant neoplasm of the commissure of lip presenting at an advanced stage where the disease is not amenable to surgical resection but where the patient retains adequate performance status and is considered fit for systemic treatment.

Advanced, inoperable lip cancer in patients fit for chemotherapy represents a distinct clinical category requiring a palliative strategy. The goals are symptom control and, where possible, improvement in overall survival rather than curative intent.

Neo-adjuvant chemotherapy using potent combination regimens is a recognised approach in advanced, inoperable disease in fit patients, particularly when followed by concurrent radiochemotherapy.

For this scenario, the approach involves palliative radiotherapy — which may be delivered over adapted fractionation schedules — or palliative chemotherapy using platinum-based agents in combination with fluoropyrimidines. The choice between modalities and the specific regimen depend on further clinical factors detailed in the full protocol.

Full regimen, sequencing, dosing, and decision algorithm are available via the structured protocol below.